Skip to main content
MJHS
Navigation
Journal Navigation
Article Navigation
Cardiovascular comorbidities in psoriatic arthritis - study of patients from the Republic of Moldova
Psoriatic arthritis (PsA) is a chronic musculoskeletal and cutaneous inflammatory disease that affects about 20-30% of patients with psoriasis. In addition to musculoskeletal and cutaneous manifestations, patients with PsA have a higher prevalence of comorbidities compared to the general population. More than half of patients with PsA have at least one comorbidity, with up to 40% of patients having more than three comorbidities.
Clinical-epidemiological characteristics of adults hospitalized with Covid–19 in the Republic of Moldova
Galina Buta1*†, Stela Cojocaru2†, Raisa Puia3†, Tudor Costru4†, Maria Ciobanu5†
https://doi.org/10.52645/MJHS.2022.2.04
The COVID-19 pandemic has a major negative impact on health and socio-economic well-being. Understanding the characteristics of COVID-19 disease and identifying the wide range of factors affecting health and quality of life can be the key to providing viable solutions to improve the management of patients and their physical and psycho-emotional rehabilitation. The purpose of the present study was to evaluate the influence of SARS CoV-2 infection on the health status of adults hospitalized with the diagnosis of COVID-19 in the Republic of Moldova.
Impact of comorbidities on the clinical and ultrasound features of psoriatic arthritis
Psoriatic arthritis (PsA) is a chronic musculoskeletal and cutaneous inflammatory disease that affects about 20-30% of patients with psoriasis. In addition to musculoskeletal and cutaneous manifestations, patients with PsA have a higher prevalence of comorbidities compared to the general population. More than half of patients with PsA have at least one comorbidity, with up to 40% of patients having more than three comorbidities. PsA has a particularly strong association with metabolic diseases and, as a result, with cardiovascular diseases (CVD).